These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22944098)

  • 1. Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription.
    Ghaffari SH; Momeny M; Bashash D; Mirzaei R; Ghavamzadeh A; Alimoghaddam K
    Hematology; 2012 Jul; 17(4):198-206. PubMed ID: 22944098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
    Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
    Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.
    Bashash D; Ghaffari SH; Zaker F; Kazerani M; Hezave K; Hassani S; Rostami M; Alimoghaddam K; Ghavamzadeh A
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1115-25. PubMed ID: 23293885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.
    Zaki Dizaji M; Ghaffari SH; Hosseini E; Alizadeh N; Rostami S; Momeny M; Alimoghaddam K; Ghavamzadeh A
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e21-e30. PubMed ID: 27770503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism.
    Ghaffari SH; Yousefi M; Dizaji MZ; Momeny M; Bashash D; Zekri A; Alimoghaddam K; Ghavamzadeh A
    Asian Pac J Cancer Prev; 2016; 17(3):1553-64. PubMed ID: 27039805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Effect of Deferoxamine and Arsenic Trioxide on Viability and Vitality of APL Like Cell Line.
    Ghaffari K; Bayat A; Ghasemi A
    Ethiop J Health Sci; 2023 Jul; 33(4):703-710. PubMed ID: 38784214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Vivas-Mejía PE; Ozpolat B; Chen X; Lopez-Berestein G
    Int J Cancer; 2009 Jul; 125(2):264-75. PubMed ID: 19408305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4).
    Hassani S; Khaleghian A; Ahmadian S; Alizadeh S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Ann Hematol; 2018 Jan; 97(1):83-93. PubMed ID: 29159499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
    Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
    Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.
    Yaghmaie M; Mozdarani H; Alimoghaddam K; Ghaffari SH; Ghavamzadeh A; Hajhashemi M
    Med Oncol; 2012 Jun; 29(2):1209-16. PubMed ID: 21544632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide suppresses transcription of hTERT through down-regulation of multiple transcription factors in HL-60 leukemia cells.
    Zhang Y; Sun M; Shi W; Yang Q; Chen C; Wang Z; Zhou X
    Toxicol Lett; 2015 Jan; 232(2):481-9. PubMed ID: 25436934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
    Hassani S; Ghaffari SH; Zaker F; Mirzaee R; Mardani H; Bashash D; Zekri A; Yousefi M; Zaghal A; Alimoghaddam K; Ghavamzadeh A
    Ann Hematol; 2013 Sep; 92(9):1207-20. PubMed ID: 23645216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.
    Bashash D; Ghaffari SH; Mirzaee R; Alimoghaddam K; Ghavamzadeh A
    Leuk Lymphoma; 2013 Mar; 54(3):561-8. PubMed ID: 22957790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL.
    Humbert M; Federzoni EA; Tschan MP
    J Leukoc Biol; 2017 Dec; 102(6):1357-1370. PubMed ID: 28978663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
    Dbaibo GS; Kfoury Y; Darwiche N; Panjarian S; Kozhaya L; Nasr R; Abdallah M; Hermine O; El-Sabban M; de Thé H; Bazarbachi A
    Haematologica; 2007 Jun; 92(6):753-62. PubMed ID: 17550847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
    Ikeda T; Kimura F; Nakata Y; Sato K; Ogura K; Motoyoshi K; Sporn M; Kufe D
    Cell Death Differ; 2005 May; 12(5):523-31. PubMed ID: 15746941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription.
    Bashash D; Ghaffari SH; Zaker F; Hezave K; Kazerani M; Ghavamzadeh A; Alimoghaddam K; Mosavi SA; Gharehbaghian A; Vossough P
    Cancer Invest; 2012 Jan; 30(1):57-64. PubMed ID: 22236190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.
    Zhang XH; Feng R; Lv M; Jiang Q; Zhu HH; Qing YZ; Bao JL; Huang XJ; Zheng XL
    Leuk Res; 2013 Dec; 37(12):1719-25. PubMed ID: 24211095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells.
    Lunghi P; Costanzo A; Levrero M; Bonati A
    Blood; 2004 Jul; 104(2):519-25. PubMed ID: 15031205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.